EW Operating Cash Flow Growth
Edwards Lifesciences · Operating Cash Flow Growth
EW Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported124.64%period ending
EW Quarterly Cash from Operations YoY % (-28.26% → 124.64%)
Year-over-year change
High-resolution chart · PNG
EW operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 124.6382% | |
| -84.3795% | |
| 453.6471% | |
| 63.0756% | |
| -21.8843% | |
| 624.1121% | |
| -193.3382% | |
| -14.5079% | |
| 1,005.6548% | |
| -117.0328% | |
| -51.6973% | |
| 32.7848% | |
| -89.8856% | |
| 7.0917% | |
| -24.3041% | |
| -41.7372% | |
| -36.8561% | |
| -2.396% | |
| -6.6% | |
| 146.136% | |
| 127.5519% | |
| 45.1691% | |
| 0.1502% | |
| -50.5831% | |
| -32.2392% | |
| 13,700% | |
| 36.314% | |
| 27.7534% | |
| 143.3666% | |
| -99.0086% | |
| -19.4834% | |
| 10.1351% | |
| -29.0845% | |
| 17.9267% | |
| 80.9547% | |
| 50.9471% | |
| 3.8886% | |
| 19.7946% | |
| 93.738% | |
| 1.679% | |
| 11.8754% | |
| 46.1119% | |
| 11.3734% | |
| 1,559.8361% | |
| -78.1362% | |
| -47.2282% | |
| -16.2624% | |
| -91.7063% | |
| 512.5984% | |
| 59.1065% | |
| -11.9462% | |
| 12.0335% | |
| -13.4877% | |
| 384.3648% | |
| -11.6702% | |
| 35.0823% | |
| 147.5548% | |
| -306.0403% | |
| 52.234% | |
| 0.8299% | |
| 23.5417% | |
| 14.6154% | |
| 42.6404% | |
| 34.8252% | |
| -24.8826% | |
| 136.1111% | |
| -18.1366% | |
| 418.1159% | |
| 120.3448% | |
| -220.4013% | |
| 4.6814% | |
| -76.7677% | |
| -23.2804% | |
| -17.1745% | |
| 9.8571% | |
| -1.3289% | |
| -4.5455% | |
| -40.8197% | |
| 58.0135% | |
| 54.359% | |
| 21.4724% | |
| 191.866% | |
| -12.9666% | |
| -39.9076% | |
| 13.5889% | |
| -42.1053% | |
| -25.5848% | |
| 145.8333% | |
| -20.4986% | |
| 519.7674% | |
| 44.9153% | |
| -14.0065% | |
| -17.2018% | |
| -855.5556% | |
| 1.5054% | |
| 7.7193% | |
| 30.9309% | |
| 87.6712% | |
| -6.0606% | |
| -32.9412% |